I would have thought a takeover offer would be make by now as for Novartis to wait and we get OTAT tick, FDA aGVHD tick then one would imagine that their bid would have to be substantially higher. However how this is dragging on and lack of progress updates you can not completely rule out a takeover offer imo.
Any thoughts on a hypothetical takeover bid? $4 to $6 per share, or would it need to be around the ATH of $10 per share?
New Covid 19 treatment, page-179
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |